Ifi27l2a Facilitates the Recruitment of Pathogenic T Cells by Retinal Microglia in the Initiation Phase of Experimental Autoimmune Uveoretinitis
Glia · 2026
DOI: 10.1002/glia.70247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2026. Verfasst von Wenna Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Henan International Joint Research Laboratory for Ocular Immunology and Retinal Injury Repair, Henan Province Eye Hospit…. Hauptthemen laut MEDLINE: Microglia, Retinitis, Retina, Uveitis. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, Henan Provincial Medical Science and Technology Research Joint Venture Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
The mechanisms by which pathogenic T cells enter the immune‐privileged retina at the onset of uveitis remain unclear. To identify regulatory targets that promote retinal inflammation, we established an experimental autoimmune uveoretinitis (EAU) model by immunizing C57BL/6J mice with IRBP 651–670 and dynamically evaluated retinal inflammation after induction; fundus lesions were prominent, with the first 14 days representing the initiation phase, Days 14–28 the amplification phase, Days 28–35 the peak phase, and Days 35–42 the regression phase. We characterized retinal cellular alterations from the pre‐inflammatory stage to the peak stage using single‐cell transcriptomic analysis, and found that retinal immune cells changed in parallel with EAU severity, while immune‐cell interactions were strongest on Day 14, especially between microglia and T cells through multiple chemokine‐related pathways. We then identified key cell populations and candidate targets through integrated analyses and functional validation, and Ifi27l2a emerged as a core gene associated with inflammatory and immune responses in retinal microglia on Day 14. In vitro knockdown of Ifi27l2a in LPS‐activated BV‐2 cells reduced inflammatory mediator production and abolished Th1/Th17 induction. In vivo targeting of Ifi27l2a attenuated EAU severity and restored the balance of T‐cell subsets. These findings indicate that microglia are highly activated before retinal inflammation becomes prominent and that Ifi27l2a regulates this early pathogenic process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Henan International Joint Research Laboratory for Ocular Immunology and Retinal Injury Repair, Henan Province Eye Hospital, The First Affiliated Hospital of Zhengzhou University, Zhengzhou,…
- Eye Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.
Förderung
- Natural Science Foundation of Henan Province
- Henan Provincial Medical Science and Technology Research Joint Venture Project
- National Natural Science Foundation of China
Zitieren
APA
Gao, W., Wu, P., Xie, K., Zhou, P., Jin, B., Zhu, H., Li, F., Wang, Y., Lei, B., Jin, X., & Du, L. (2026). Ifi27l2a Facilitates the Recruitment of Pathogenic T Cells by Retinal Microglia in the Initiation Phase of Experimental Autoimmune Uveoretinitis. Glia. https://doi.org/10.1002/glia.70247
Vancouver
Gao W, Wu P, Xie K, Zhou P, Jin B, Zhu H, et al. Ifi27l2a Facilitates the Recruitment of Pathogenic T Cells by Retinal Microglia in the Initiation Phase of Experimental Autoimmune Uveoretinitis. Glia. 2026. doi:10.1002/glia.70247
BibTeX
@article{Gao2026,
author = {Gao, Wenna and Wu, Pucheng and Xie, Kunpeng and Zhou, Pengyi and Jin, Bo and Zhu, Haiyan and Li, Fuzhen and Wang, You and Lei, Bo and Jin, Xuemin and Du, Liping},
title = {Ifi27l2a Facilitates the Recruitment of Pathogenic T Cells by Retinal Microglia in the Initiation Phase of Experimental Autoimmune Uveoretinitis},
journal = {Glia},
year = {2026},
doi = {10.1002/glia.70247}
}
EUVIMED